Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomegaly | 10 | 2011 | 41 | 2.300 |
Why?
|
| Ethanol | 4 | 2015 | 192 | 1.360 |
Why?
|
| Heart | 6 | 2019 | 180 | 1.360 |
Why?
|
| Myocytes, Cardiac | 9 | 2019 | 166 | 1.350 |
Why?
|
| Myocardium | 6 | 2014 | 235 | 1.270 |
Why?
|
| Myocardial Contraction | 6 | 2015 | 48 | 1.130 |
Why?
|
| Angiotensin II | 4 | 2011 | 97 | 1.080 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2014 | 70 | 0.990 |
Why?
|
| Captopril | 3 | 2011 | 8 | 0.850 |
Why?
|
| Heart Rate | 2 | 2014 | 253 | 0.850 |
Why?
|
| Overnutrition | 1 | 2022 | 6 | 0.830 |
Why?
|
| Caloric Restriction | 1 | 2022 | 32 | 0.810 |
Why?
|
| Heart Failure | 4 | 2019 | 235 | 0.810 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2014 | 136 | 0.760 |
Why?
|
| Signal Transduction | 10 | 2019 | 1908 | 0.700 |
Why?
|
| Potassium Channels | 2 | 2010 | 75 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2014 | 269 | 0.650 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2015 | 55 | 0.590 |
Why?
|
| Rats | 14 | 2015 | 3483 | 0.570 |
Why?
|
| Capillaries | 1 | 2015 | 26 | 0.510 |
Why?
|
| Alcoholism | 1 | 2018 | 240 | 0.510 |
Why?
|
| Cardiotonic Agents | 2 | 2013 | 37 | 0.500 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2014 | 2 | 0.500 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2010 | 73 | 0.490 |
Why?
|
| Coronary Vessels | 1 | 2015 | 85 | 0.490 |
Why?
|
| Microvessels | 1 | 2014 | 28 | 0.480 |
Why?
|
| Exercise | 2 | 2022 | 613 | 0.480 |
Why?
|
| Protein Kinase C | 2 | 2004 | 120 | 0.460 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 2013 | 1 | 0.450 |
Why?
|
| Nitrates | 1 | 2013 | 40 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2013 | 1618 | 0.450 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2013 | 11 | 0.450 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 103 | 0.440 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 37 | 0.440 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 237 | 0.430 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1207 | 0.430 |
Why?
|
| Animals | 21 | 2019 | 15081 | 0.420 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 56 | 0.420 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2011 | 1 | 0.400 |
Why?
|
| Dietary Supplements | 1 | 2013 | 208 | 0.390 |
Why?
|
| Oxidative Stress | 2 | 2014 | 938 | 0.390 |
Why?
|
| Calcium Channels, L-Type | 1 | 2011 | 20 | 0.390 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2008 | 27 | 0.390 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2011 | 61 | 0.380 |
Why?
|
| Sex Characteristics | 2 | 2013 | 230 | 0.370 |
Why?
|
| Receptor Cross-Talk | 1 | 2010 | 17 | 0.360 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 306 | 0.360 |
Why?
|
| Male | 17 | 2015 | 20025 | 0.340 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2008 | 2 | 0.320 |
Why?
|
| Apoptosis | 6 | 2015 | 1398 | 0.310 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2004 | 69 | 0.280 |
Why?
|
| Atrial Function, Left | 1 | 2005 | 2 | 0.270 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 47 | 0.270 |
Why?
|
| Receptors, CXCR4 | 2 | 2019 | 69 | 0.250 |
Why?
|
| Atrial Function | 1 | 2004 | 1 | 0.250 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 1371 | 0.240 |
Why?
|
| Phosphorylation | 6 | 2014 | 928 | 0.240 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 109 | 0.230 |
Why?
|
| Angiotensin I | 1 | 2003 | 5 | 0.220 |
Why?
|
| Cocaine | 1 | 2005 | 232 | 0.220 |
Why?
|
| Nicotine | 1 | 2005 | 257 | 0.220 |
Why?
|
| Renin-Angiotensin System | 1 | 2003 | 36 | 0.220 |
Why?
|
| Humans | 13 | 2022 | 37093 | 0.220 |
Why?
|
| Kidney Glomerulus | 2 | 2014 | 84 | 0.210 |
Why?
|
| Calcium Signaling | 2 | 2013 | 101 | 0.210 |
Why?
|
| NF-kappa B | 3 | 2014 | 339 | 0.200 |
Why?
|
| Heart Ventricles | 2 | 2015 | 110 | 0.200 |
Why?
|
| Aging | 1 | 2005 | 664 | 0.190 |
Why?
|
| Patch-Clamp Techniques | 2 | 2011 | 223 | 0.180 |
Why?
|
| Time Factors | 5 | 2013 | 1742 | 0.180 |
Why?
|
| Homeostasis | 2 | 2013 | 188 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2019 | 933 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 95 | 0.170 |
Why?
|
| Cell Physiological Phenomena | 1 | 2018 | 9 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 643 | 0.160 |
Why?
|
| Quality of Life | 1 | 2022 | 481 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2011 | 859 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 88 | 0.150 |
Why?
|
| Cardiovascular System | 1 | 2017 | 33 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 161 | 0.140 |
Why?
|
| Endothelial Cells | 3 | 2014 | 308 | 0.140 |
Why?
|
| Ventricular Function, Left | 2 | 2013 | 96 | 0.130 |
Why?
|
| Diet | 1 | 2022 | 801 | 0.130 |
Why?
|
| Heart Atria | 2 | 2005 | 26 | 0.130 |
Why?
|
| Rats, Transgenic | 1 | 2014 | 27 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 54 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 626 | 0.120 |
Why?
|
| Morpholines | 1 | 2014 | 69 | 0.120 |
Why?
|
| Chromones | 1 | 2014 | 54 | 0.120 |
Why?
|
| Cell Survival | 2 | 2014 | 864 | 0.120 |
Why?
|
| Nitric Oxide | 2 | 2013 | 316 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 155 | 0.110 |
Why?
|
| Sarcomeres | 1 | 2013 | 8 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2014 | 444 | 0.110 |
Why?
|
| Exercise Test | 1 | 2013 | 67 | 0.110 |
Why?
|
| Alcoholic Beverages | 1 | 2013 | 15 | 0.110 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 108 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1039 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2013 | 51 | 0.110 |
Why?
|
| Cell Separation | 1 | 2013 | 93 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 57 | 0.110 |
Why?
|
| Ischemic Preconditioning | 1 | 2013 | 48 | 0.110 |
Why?
|
| Progesterone | 1 | 2013 | 113 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 282 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 29 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 75 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2013 | 89 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2017 | 400 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 98 | 0.110 |
Why?
|
| Collagen Type IV | 1 | 2012 | 48 | 0.110 |
Why?
|
| Mice | 5 | 2019 | 5913 | 0.100 |
Why?
|
| Fibronectins | 1 | 2012 | 66 | 0.100 |
Why?
|
| Minority Groups | 1 | 2017 | 596 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 212 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 105 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 67 | 0.100 |
Why?
|
| Estrogens | 1 | 2013 | 202 | 0.100 |
Why?
|
| Estradiol | 1 | 2013 | 262 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 519 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2013 | 308 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2013 | 167 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 17 | 0.090 |
Why?
|
| Vitamin D | 1 | 2013 | 196 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 480 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1015 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2008 | 7 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 103 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 99 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2008 | 223 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 122 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2008 | 129 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2015 | 1518 | 0.080 |
Why?
|
| Rats, Inbred OLETF | 1 | 2006 | 4 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2006 | 8 | 0.070 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2006 | 16 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 664 | 0.070 |
Why?
|
| Female | 3 | 2013 | 20969 | 0.070 |
Why?
|
| Isoproterenol | 2 | 2019 | 36 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2005 | 100 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2005 | 62 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2004 | 34 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2004 | 110 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 190 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2005 | 162 | 0.060 |
Why?
|
| Young Adult | 1 | 2013 | 4268 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2003 | 48 | 0.050 |
Why?
|
| Models, Biological | 1 | 2006 | 677 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 73 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 76 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2003 | 217 | 0.050 |
Why?
|
| RNA Interference | 2 | 2012 | 243 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2004 | 646 | 0.050 |
Why?
|
| Pregnancy | 1 | 2005 | 1549 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 12 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2019 | 34 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 66 | 0.040 |
Why?
|
| Hypertension | 1 | 2005 | 796 | 0.040 |
Why?
|
| Financing, Government | 1 | 2017 | 19 | 0.040 |
Why?
|
| Aged | 1 | 2008 | 6741 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2005 | 10 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2017 | 198 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 233 | 0.030 |
Why?
|
| Sirolimus | 2 | 2005 | 60 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1609 | 0.030 |
Why?
|
| Middle Aged | 1 | 2008 | 10129 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 20 | 0.030 |
Why?
|
| Adipokines | 1 | 2013 | 24 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2013 | 88 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 85 | 0.030 |
Why?
|
| Stem Cells | 1 | 2013 | 141 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2012 | 110 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2012 | 207 | 0.030 |
Why?
|
| Vasodilation | 1 | 2011 | 65 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 523 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2011 | 85 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 161 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2010 | 28 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2011 | 118 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 320 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 356 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 131 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 86 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 972 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4223 | 0.020 |
Why?
|
| Thiocarbamates | 1 | 2005 | 4 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 2005 | 29 | 0.020 |
Why?
|
| Organ Size | 1 | 2005 | 157 | 0.020 |
Why?
|
| Models, Animal | 1 | 2005 | 134 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 617 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 610 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 434 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 225 | 0.010 |
Why?
|
| Antioxidants | 1 | 2005 | 416 | 0.010 |
Why?
|